On January 6, 2013, Dr. David Weng resigned as Chief Medical Officer and Senior Vice President Clinical Services of TetraLogic Pharmaceuticals Corporation, with such resignation to be effective as of February 28, 2014. Dr. Lesley Russell, the company's Chief Operating Officer, will undertake the role of Chief Medical Officer for the company upon Dr. Weng's departure.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -99.00% |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 24 | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.12% | 21.96B | |
-9.28% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- TLOG Stock
- News TetraLogic Pharmaceuticals Corporation
- TetraLogic Pharmaceuticals Corporation Announces Executive Changes